Robert S. Laitman, MD, on Unpacking Schizophrenia: The Role of Clozapine and Shattering the Stigma

Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to treatment has helped the majority of his patients achieve meaningful recovery.

Robert S Laitman, MD, is an internal medicine physician at Bronx Westchester Medical Group in New York. He is on the Board of Directors for the Schizophrenia and Related Disorders Alliance of America, and is also a board member of the National Alliance of Mental Illness - New York. Over the last 10 years, he has developed a practice taking care of people with psychotic disorders after his son, Daniel, received a diagnosis of schizophrenia in 2006.

Dr Laitman, his family, and his colleague authored the book, "Clozapine: Meaningful Recovery from Schizophrenia."

Published in partnership with  

References:

1. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305-326. https://www.ncbi.nlm.nih.gov/pubmed/8782288.

2. Kane JM, Schooler NO, Marcy P, et al. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. J Clin Psychiatry. 2015;76(3):240-246. doi:10.4088/JCP.14m09289.

3. Dixon LB, Goldman HH, Bennett ME, et al. Implementing coordinated specialty care for early psychosis: The RAISE Connection Program. Psychiatr Serv. 2015; 66(7):691-8. doi:10.1176/appi.ps.201400281.